Holen Sie sich die Stockscreener-App
17.03
0.65%
0.11
Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
41.96%
0.083
|
0.143 | 0.008 | - | - |
Operating Expenses
|
4.22%
48.57
|
46.60 | 43.29 | 41.34 | 38.87 |
| Benefits Costs and Expenses |
100.00%
-
|
153.14 | - | - | - |
| Costs And Expenses |
63.80%
48.57
|
29.65 | 43.29 | - | - |
| Operating Income/Loss |
4.37%
-48.48
|
-46.45 | -43.28 | -41.34 | -38.87 |
| Nonoperating Income/Loss |
13.57%
5.369
|
6.212 | 3.84 | 3.832 | 3.065 |
| Income/Loss From Continuing Operations Before Tax |
100.05%
0.083
|
-153.00 | 0.008 | -37.51 | -35.80 |
| Income/Loss From Continuing Operations After Tax |
7.13%
-43.11
|
-40.24 | -39.44 | -37.51 | -35.80 |
|
Net Income/Loss
|
7.13%
-43.11
|
-40.24 | -39.44 | -37.51 | -35.80 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
15,485%
35.69
|
0.229 | 29.67 | 29.60 | 28.37 |
| Diluted Average Shares |
15,485%
35.69
|
0.229 | 29.67 | 29.60 | 28.37 |
| Basic Earnings Per Share |
9.70%
-1.21
|
-1.34 | -1.33 | -1.27 | -1.26 |
| Diluted Earnings Per Share |
9.70%
-1.21
|
-1.34 | -1.33 | -1.27 | -1.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):